|
|
Vitrolife AB - Comparative Business Analysis Snapshot
Business Description
Vitrolife AB. The Group's principal activities are research, development and manufacture of fertility systems (media and equipment for infertility treatment), cell therapy and tissue engineering systems (restoring, maintaining and improving biological function of tissues), transplant systems (media and equipment for organ preservation) and bio supportive systems (hyaluronic acid products for surgical and therapeutic application). The Group operates through subsidiaries in the US, Australia and Sweden.
Competitor Analysis
This analysis compares Vitrolife AB with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
